Your browser doesn't support javascript.
loading
Multimodal survival prediction in advanced pancreatic cancer using machine learning.
Keyl, J; Kasper, S; Wiesweg, M; Götze, J; Schönrock, M; Sinn, M; Berger, A; Nasca, E; Kostbade, K; Schumacher, B; Markus, P; Albers, D; Treckmann, J; Schmid, K W; Schildhaus, H-U; Siveke, J T; Schuler, M; Kleesiek, J.
Affiliation
  • Keyl J; Department of Medical Oncology, West German Cancer Center, University Hospital Essen (AöR), University of Duisburg-Essen, Essen, Germany; Institute for AI in Medicine (IKIM), University Hospital Essen (AöR), Essen, Germany; German Cancer Consortium (DKTK), Partner site University Hospital Essen (AöR
  • Kasper S; Department of Medical Oncology, West German Cancer Center, University Hospital Essen (AöR), University of Duisburg-Essen, Essen, Germany; German Cancer Consortium (DKTK), Partner site University Hospital Essen (AöR), Essen, Germany; Medical Faculty, University of Duisburg-Essen, Essen, Germany.
  • Wiesweg M; Department of Medical Oncology, West German Cancer Center, University Hospital Essen (AöR), University of Duisburg-Essen, Essen, Germany; Medical Faculty, University of Duisburg-Essen, Essen, Germany.
  • Götze J; Department of Internal Medicine II, Oncology, Hematology, BMT and Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Schönrock M; Department of Internal Medicine II, Oncology, Hematology, BMT and Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Sinn M; Department of Internal Medicine II, Oncology, Hematology, BMT and Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Berger A; Institute for AI in Medicine (IKIM), University Hospital Essen (AöR), Essen, Germany.
  • Nasca E; Institute for AI in Medicine (IKIM), University Hospital Essen (AöR), Essen, Germany.
  • Kostbade K; Department of Medical Oncology, West German Cancer Center, University Hospital Essen (AöR), University of Duisburg-Essen, Essen, Germany; Medical Faculty, University of Duisburg-Essen, Essen, Germany.
  • Schumacher B; Department of Gastroenterology, Elisabeth Hospital Essen, Essen, Germany.
  • Markus P; Department of General Surgery and Traumatology, Elisabeth Hospital Essen, Essen, Germany.
  • Albers D; Department of Gastroenterology, Elisabeth Hospital Essen, Essen, Germany.
  • Treckmann J; Department of General, Visceral and Transplant Surgery, West German Cancer Center, University Hospital Essen (AöR), Essen, Germany.
  • Schmid KW; Medical Faculty, University of Duisburg-Essen, Essen, Germany; Institute of Pathology, West German Cancer Center, University Hospital Essen (AöR), Essen, Germany.
  • Schildhaus HU; Medical Faculty, University of Duisburg-Essen, Essen, Germany; Institute of Pathology, West German Cancer Center, University Hospital Essen (AöR), Essen, Germany.
  • Siveke JT; Department of Medical Oncology, West German Cancer Center, University Hospital Essen (AöR), University of Duisburg-Essen, Essen, Germany; Medical Faculty, University of Duisburg-Essen, Essen, Germany; Bridge Institute of Experimental Tumor Therapy (BIT), West German Cancer Center, University Hospita
  • Schuler M; Department of Medical Oncology, West German Cancer Center, University Hospital Essen (AöR), University of Duisburg-Essen, Essen, Germany; German Cancer Consortium (DKTK), Partner site University Hospital Essen (AöR), Essen, Germany; Medical Faculty, University of Duisburg-Essen, Essen, Germany.
  • Kleesiek J; Institute for AI in Medicine (IKIM), University Hospital Essen (AöR), Essen, Germany; Medical Faculty, University of Duisburg-Essen, Essen, Germany.
ESMO Open ; 7(5): 100555, 2022 10.
Article in En | MEDLINE | ID: mdl-35988455

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Adenocarcinoma Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: ESMO Open Year: 2022 Document type: Article Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Adenocarcinoma Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: ESMO Open Year: 2022 Document type: Article Country of publication: